These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6295402)

  • 1. Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme in vitro.
    MacGregor JS; Resnick LM; Laragh JH
    Biochem Biophys Res Commun; 1982 Nov; 109(2):556-61. PubMed ID: 6295402
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinociceptive activity of TRH metabolites in the mouse.
    Reny-Palasse V; Rips R
    Pain; 1987 Aug; 30(2):259-269. PubMed ID: 3118323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
    Kagabu Y; Mishiba T; Okino T; Yanagisawa T
    Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically stable analogues of TRH with increased neuropharmacological potency.
    Brewster D; Dettmar PW; Metcalf G
    Neuropharmacology; 1981 May; 20(5):497-503. PubMed ID: 6787451
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows.
    Koskinen LO
    Br J Pharmacol; 1986 Mar; 87(3):509-19. PubMed ID: 3099875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and neuromodulatory effects of TRH-related peptides: inhibitory activity on catecholamine release in vitro.
    Brunetti L; Chiavaroli A; Cocco A; Ferrante C; Ferrucci A; Luisi G; Orlando G; Pinnen F; Vacca M
    Pharmacol Rep; 2013; 65(4):823-35. PubMed ID: 24145076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analogue of thyrotropin releasing hormone with improved biological stability both in vitro and in vivo.
    Brewster D; Rance MJ
    Biochem Pharmacol; 1980 Oct; 29(19):2619-23. PubMed ID: 6775640
    [No Abstract]   [Full Text] [Related]  

  • 8. TRH stimulation of in vivo GH release in the domestic fowl. Influence of TRH metabolites and effect of age on in vitro degradation of TRH.
    Scanes CG; Harvey S; Bolaffi JL
    Neuroendocrinology; 1985 Jan; 40(1):33-8. PubMed ID: 3918278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
    McDermott AM; Wilkin GP; Dickinson SL
    Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of ethanol-induced decrease in rat brain cGMP concentration by histidyl-proline diketopiperazine, a thyrotropin releasing hormone metabolite.
    Yanagisawa T; Prasad C; Williams J; Peterkofsky A
    Biochem Biophys Res Commun; 1979 Feb; 86(4):1146-53. PubMed ID: 219860
    [No Abstract]   [Full Text] [Related]  

  • 11. TRH analogue, RX 77368, injected into dorsal vagal complex stimulates gastric secretion in rats.
    Stephens RL; Ishikawa T; Weiner H; Novin D; Taché Y
    Am J Physiol; 1988 May; 254(5 Pt 1):G639-43. PubMed ID: 3129948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects.
    Pekary AE; Stephens R; Simard M; Pang XP; Smith V; DiStefano JJ; Hershman JM
    Neuroendocrinology; 1990 Dec; 52(6):618-25. PubMed ID: 2126612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of TRH thionalogue and its diastereoisomers.
    Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M
    Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing-hormone (TRH) and its physiological metabolite TRH-OH inhibit Na+ channel activity in mammalian septal neurons.
    López-Barneo J; Castellano A; Toledo-Aral J
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8150-4. PubMed ID: 2172974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug derivatives of thyrotropin-releasing hormone and other peptides.
    Bundgaard H; Møss J
    Biochem Soc Trans; 1989 Oct; 17(5):947-9. PubMed ID: 2515981
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermoregulation in rats: opposing effects of thyrotropin releasing hormone and its metabolite histidyl-proline diketopiperazine.
    Prasad C; Matsui T; Williams J; Peterkofsky A
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1582-7. PubMed ID: 105738
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of prolactin secretion by histidyl-proline-diketopiperazine.
    Bauer K; Gräf KJ; Faivre-Bauman A; Beier S; Tixier-Vidal A; Kleinkauf H
    Nature; 1978 Jul; 274(5667):174-5. PubMed ID: 26883
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia.
    Bhargava HN
    Life Sci; 1980 Mar; 26(11):845-850. PubMed ID: 6246320
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of ethanol narcosis by histidyl-proline diketopiperazine.
    Prasad C; Matsui T; Peterkofsky A
    Nature; 1977 Jul; 268(5616):142-4. PubMed ID: 413043
    [No Abstract]   [Full Text] [Related]  

  • 20. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.